Title:
Clinical Profile and Outcome of COVID-19 Among Immunocompromised Children

Simple item page
dc.contributor.authorSunil Kumar Rao
dc.contributor.authorAshutosh Kumar
dc.contributor.authorRajniti Prasad
dc.contributor.authorVineeta Gupta
dc.contributor.authorOm Prakash Mishra
dc.date.accessioned2026-02-07T10:39:49Z
dc.date.issued2021
dc.description.abstractThis retrospective study describes the clinical profile, risk of infection and outcome of coronavirus disease-19 in immunocompromised children. It was found that children on immunosuppressant medication has 2.89 times increased risk of infection (P=0.01). Disease manifestation was asymptomatic (P=0.01) or mild with predominant gastrointestinal symptoms (P=0.02) without alteration in immunosuppressive treatment regime. © 2021, Indian Academy of Pediatrics.
dc.identifier.doi10.1007/s13312-021-2267-6
dc.identifier.issn196061
dc.identifier.urihttps://doi.org/10.1007/s13312-021-2267-6
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/37611
dc.publisherSpringer
dc.subjectChildren
dc.subjectCOVID-19
dc.subjectImmunocompromised
dc.subjectOutcome
dc.titleClinical Profile and Outcome of COVID-19 Among Immunocompromised Children
dc.typePublication
dspace.entity.typeLetter

Files

Collections

2021
An Initiative by BHU – Central Library
Powered by Dspace